ADAMTS1 and central nervous system cancer: Looking back to the data of ADAMTS1 as bad prognosis factor at early stages of glioma evolution, we postulate the major contribution of this protease in stem-like cells during such period, also according to the specific characteristics of the TME in that earlier tumor phase.